Qi Zhu

机构：China Pharmaceutical University, Chinese Academy of Sciences, Shanghai Institute of Materia Medica · ORCID：0000-0003-1195-4582

发表论文 72 篇 · 总被引 767 次 · h-index 15

代表论文

• Ubiquitin-specific protease 14 targets PFKL-mediated glycolysis to promote the proliferation and migration of oral squamous cell carcinoma (2024 · Journal of Translational Medicine · 被引 15)
• The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis (2025 · Journal of Inflammation Research · 被引 11)
• Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation (2024 · Cancer Immunology Immunotherapy · 被引 11)
• Interleukins and Psoriasis (2024 · Journal of Cutaneous Medicine and Surgery · 被引 10)
• Influenza A Virus and Mycoplasma pneumoniae Coinfection Mediates Immune Dysregulation and Exacerbates Disease Severity (2025 · International Journal of Molecular Sciences · 被引 7)
• New advances in small molecule drugs targeting NMDA receptors (2025 · Acta Pharmacologica Sinica · 被引 4)